SAROJA — Saroja Pharma Industries India Balance Sheet
0.000.00%
- IN₹168.86m
- IN₹263.42m
- IN₹537.27m
- 16
- 80
- 45
- 44
Annual balance sheet for Saroja Pharma Industries India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.041 | 2.65 | 3.64 | 3.22 | 3.32 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 72.7 | 142 | 112 | 163 | 266 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 81 | 151 | 161 | 176 | 272 |
| Net Property, Plant And Equipment | 0.831 | 3.42 | 40 | 86.4 | 111 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 82.2 | 155 | 213 | 266 | 396 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 58.7 | 97.9 | 134 | 92.9 | 225 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 72.9 | 115 | 163 | 119 | 239 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 9.36 | 40.3 | 50.9 | 146 | 157 |
| Total Liabilities & Shareholders' Equity | 82.2 | 155 | 213 | 266 | 396 |
| Total Common Shares Outstanding |